🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Adam D. Pfefferle

ORCID: 0000-0002-4924-1767

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies”.

Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies

UNC Libraries(2020)10.17615/wadb-4174

N/A

0DataRank · unranked

17 citations

R. S. Cook, M. G. Kuba, C. M. Perou, J. M. Balko, V. Sanchez +7 more

Comparative Oncogenomics Implicates the Neurofibromin 1 Gene (NF1) as a Breast Cancer Driver

UNC Libraries(2020)10.17615/h6pr-1z16

N/A

0DataRank · unranked

12 citations

T. L. Southard, Adam D. Pfefferle, John C. Schimenti, A. J. McNairn, E. G. Cerami +5 more

Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models

UNC Libraries(2020)10.17615/n3y7-sa69

N/A

0DataRank · unranked

0 citations

Jian Jin, Søren M. Johnson, Patrick M. Dillon, Austin J. Combest, David B. Darr +9 more

c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression

UNC Libraries(2020)10.17615/dpd2-z189

N/A

0DataRank · unranked

0 citations

Carla L. Van Den Berg, Nancy D. Ebelt, Charles M. Perou, Michael A. Cantrell, Adam D. Pfefferle

Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts

UNC Libraries(2020)10.17615/dkm6-h153

N/A

0DataRank · unranked

0 citations

Adam D. Pfefferle, Benjamin T. Spike, J. Chuck Harrell, Jeffrey M. Rosen, Maria I. Torres‐Arzayus +7 more

A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.003

N/A

0DataRank · unranked

9 citations

Michael W. Sill, Paola A. Gehrig, Jason D. Merker, David L. Corcoran, Adam D. Pfefferle +15 more